Treace Medical Concepts (TMCI) Total Debt (2020 - 2026)

Treace Medical Concepts has reported Total Debt for 7 years, with the latest figure at $57.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 7.81% year-over-year to $57.6 million; the trailing twelve-month figure through Mar 2026 stood at $57.6 million (up 7.81% YoY), and the FY2025 full-year result was $57.3 million, up 7.55% from the prior year.
• Total Debt for Q1 2026 stood at $57.6 million, roughly flat from $57.3 million in the prior quarter.
• The five-year high for Total Debt was $57.6 million in Q1 2026, with the low at $29.4 million in Q1 2022.
• Historically, Total Debt has averaged $52.3 million across 5 years, with a median of $53.1 million in 2024.
• Annual changes were most pronounced in 2022 — Total Debt surged 79.53% — and 2024, when it rose 0.56%.
• Treace Medical Concepts' Total Debt stood at $52.7 million in 2022, then rose by 0.56% to $53.0 million in 2023, then rose by 0.56% to $53.3 million in 2024, then gained by 7.55% to $57.3 million in 2025, then increased by 0.47% to $57.6 million in 2026.
• The last three Total Debt figures came in at $57.6 million (Q1 2026), $57.3 million (Q4 2025), and $55.3 million (Q3 2025), per Business Quant data.